ProShare Advisors LLC

Position in CMPX — Compass Therapeutics, Inc.

CIK 1357955 BETHESDA, MD

Position in CMPX

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$37,595

-$61,343 QoQ

Shares Held

17,167

-8.2% QoQ

Ownership

0.010%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#151

of 213 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. CMPX ranks #160 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	287,847	$142,982,240
2	REGN	Regeneron Pharmaceuticals, Inc.	119,240	$74,350,909
3	ALNY	Alnylam Pharmaceuticals, Inc.	128,514	$38,686,569
4	INCY	Incyte Corp	48,152	$5,458,510
5	MRNA	Moderna, Inc.	70,621	$4,945,588
6	CYTK	Cytokinetics Inc	27,121	$2,310,437
7	TECH	BIO-TECHNE Corp	30,597	$2,161,678
8	KRYS	Krystal Biotech, Inc.	4,760	$1,769,149

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$37,595	17,167	-8.2%	Shares	Sole	2026-08-11
2026-03-31	$98,938	18,703	-22.0%	Shares	Sole	2026-04-27
2025-12-31	$128,729	23,972	+41.0%	Shares	Sole	2026-02-06
2025-09-30	$59,514	17,004	-9.5%	Shares	Sole	2025-11-06
2025-06-30	$48,867	18,795	-14.9%	Shares	Sole	2025-08-07
2025-03-31	$41,950	22,079	-23.1%	Shares	Sole	2025-05-08
2024-12-31	$41,646	28,722	+49.0%	Shares	Sole	2025-02-14
2024-09-30	$35,458	19,271	+57.7%	Shares	Sole	2024-11-14
2024-06-30	$12,223	12,223	-25.5%	Shares	Sole	2024-08-13
2024-03-31	$32,464	16,396	+8.6%	Shares	Sole	2024-05-08
2023-12-31	$23,562	15,104	+27.4%	Shares	Sole	2024-02-14
2023-09-30	$23,356	11,856	-0.1%	Shares	Sole	2023-11-13
2023-06-30	$37,740	11,868	—	Shares	Sole	2023-08-10
No filing history on record for this holder in this stock.